OrthoPediatrics Corp. priced an underwritten public offering of 1,570,000 of its shares at $36.50 apiece.

The Warsaw, Ind.-based medical device company is offering 1,520,000 of its shares directly. OrthoPediatrics' stockholders will offer an additional 50,000 shares, the proceeds of which will not go to the company.

Underwriters will receive an option to buy up to an additional 235,500 shares.

The offering is scheduled to close Dec. 13.

Piper Jaffray and Stifel are joint book-running managers for the offering, while BTIG, JMP Securities and SunTrust Robinson Humphrey are acting as co-managers.

In August, the U.S. Food and Drug Administration approved OrthoPediatrics' PediFoot Deformity Correction System, which treats foot and ankle deformities in children.